Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nat Commun ; 12(1): 6084, 2021 10 19.
Artículo en Inglés | MEDLINE | ID: mdl-34667149

RESUMEN

Postmortem studies have revealed increased density of excitatory synapses in the brains of individuals with autism spectrum disorder (ASD), with a putative link to aberrant mTOR-dependent synaptic pruning. ASD is also characterized by atypical macroscale functional connectivity as measured with resting-state fMRI (rsfMRI). These observations raise the question of whether excess of synapses causes aberrant functional connectivity in ASD. Using rsfMRI, electrophysiology and in silico modelling in Tsc2 haploinsufficient mice, we show that mTOR-dependent increased spine density is associated with ASD -like stereotypies and cortico-striatal hyperconnectivity. These deficits are completely rescued by pharmacological inhibition of mTOR. Notably, we further demonstrate that children with idiopathic ASD exhibit analogous cortical-striatal hyperconnectivity, and document that this connectivity fingerprint is enriched for ASD-dysregulated genes interacting with mTOR or Tsc2. Finally, we show that the identified transcriptomic signature is predominantly expressed in a subset of children with autism, thereby defining a segregable autism subtype. Our findings causally link mTOR-related synaptic pathology to large-scale network aberrations, revealing a unifying multi-scale framework that mechanistically reconciles developmental synaptopathy and functional hyperconnectivity in autism.


Asunto(s)
Trastorno del Espectro Autista/metabolismo , Trastorno del Espectro Autista/fisiopatología , Sinapsis/metabolismo , Serina-Treonina Quinasas TOR/metabolismo , Adolescente , Animales , Trastorno del Espectro Autista/genética , Trastorno del Espectro Autista/patología , Encéfalo/diagnóstico por imagen , Encéfalo/metabolismo , Encéfalo/patología , Encéfalo/fisiopatología , Corteza Cerebral/diagnóstico por imagen , Corteza Cerebral/metabolismo , Corteza Cerebral/patología , Corteza Cerebral/fisiopatología , Niño , Femenino , Haploinsuficiencia , Humanos , Imagen por Resonancia Magnética , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Sinapsis/genética , Serina-Treonina Quinasas TOR/genética , Proteína 2 del Complejo de la Esclerosis Tuberosa/genética , Proteína 2 del Complejo de la Esclerosis Tuberosa/metabolismo
2.
Nat Methods ; 15(11): 969-976, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30377377

RESUMEN

Currently available inhibitory optogenetic tools provide short and transient silencing of neurons, but they cannot provide long-lasting inhibition because of the requirement for high light intensities. Here we present an optimized blue-light-sensitive synthetic potassium channel, BLINK2, which showed good expression in neurons in three species. The channel is activated by illumination with low doses of blue light, and in our experiments it remained active over (tens of) minutes in the dark after the illumination was stopped. This activation caused long periods of inhibition of neuronal firing in ex vivo recordings of mouse neurons and impaired motor neuron response in zebrafish in vivo. As a proof-of-concept application, we demonstrated that in a freely moving rat model of neuropathic pain, the activation of a small number of BLINK2 channels caused a long-lasting (>30 min) reduction in pain sensation.


Asunto(s)
Potenciales de Acción , Hiperalgesia/fisiopatología , Neuronas/fisiología , Optogenética , Dolor/fisiopatología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Proteínas Recombinantes de Fusión/metabolismo , Animales , Femenino , Luz , Masculino , Ratones Endogámicos C57BL , Neuronas/citología , Paclitaxel/toxicidad , Dolor/inducido químicamente , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes de Fusión/genética , Pez Cebra
3.
Neuron ; 98(4): 801-816.e7, 2018 05 16.
Artículo en Inglés | MEDLINE | ID: mdl-29706583

RESUMEN

Monoaminergic modulation of cortical and thalamic inputs to the dorsal striatum (DS) is crucial for reward-based learning and action control. While dopamine has been extensively investigated in this context, the synaptic effects of serotonin (5-HT) have been largely unexplored. Here, we investigated how serotonergic signaling affects associative plasticity at glutamatergic synapses on the striatal projection neurons of the direct pathway (dSPNs). Combining chemogenetic and optogenetic approaches reveals that impeding serotonergic signaling preferentially gates spike-timing-dependent long-term depression (t-LTD) at thalamostriatal synapses. This t-LTD requires dampened activity of the 5-HT4 receptor subtype, which we demonstrate controls dendritic Ca2+ signals by regulating BK channel activity, and which preferentially localizes at the dendritic shaft. The synaptic effects of 5-HT signaling at thalamostriatal inputs provide insights into how changes in serotonergic levels associated with behavioral states or pathology affect striatal-dependent processes.


Asunto(s)
Cuerpo Estriado/metabolismo , Plasticidad Neuronal/genética , Receptores de Serotonina 5-HT4/genética , Serotonina/metabolismo , Tálamo/metabolismo , Animales , Señalización del Calcio/efectos de los fármacos , Señalización del Calcio/genética , Cuerpo Estriado/citología , Cuerpo Estriado/efectos de los fármacos , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Indoles/farmacología , Canales de Potasio de Gran Conductancia Activados por el Calcio/metabolismo , Depresión Sináptica a Largo Plazo , Ratones , Ratones Transgénicos , Vías Nerviosas , Plasticidad Neuronal/efectos de los fármacos , Optogenética , Piperidinas/farmacología , Propano/análogos & derivados , Propano/farmacología , Antagonistas del Receptor de Serotonina 5-HT4/farmacología , Sulfonamidas/farmacología , Sinapsis/efectos de los fármacos , Sinapsis/metabolismo , Tálamo/citología , Tálamo/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA